We are live on
!
Find out more
DA
Dillon & Associates Portfolio holdings
AUM
$726M
1-Year Est. Return
18.59%
This Fund
S&P 500
This Quarter
Est. Return
-10.96%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$263M
AUM Growth
-$39.5M
(-13%)
Cap. Flow
-$2.8M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
45.72%
Holding
73
New
1
Increased
23
Reduced
30
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$954K |
| 2 |
Euronet Worldwide
EEFT
|
+$524K |
| 3 |
Paycom
PAYC
|
+$448K |
| 4 |
Constellation Brands
STZ
|
+$445K |
| 5 |
Salesforce
CRM
|
+$416K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$607K |
| 2 |
Core Laboratories
CLB
|
+$516K |
| 3 |
SLB Ltd
SLB
|
+$503K |
| 4 |
Procter & Gamble
PG
|
+$490K |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$455K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.89% |
| 2 | Technology | 20.91% |
| 3 | Consumer Staples | 10.16% |
| 4 | Communication Services | 9.93% |
| 5 | Financials | 9.62% |
Similar funds
TC
F
SDH
SCM
MWP
FAN
TFHU
AGAM
Dillon & Associates's Q4 2018 Portfolio in Review
As of Q4 2018, Dillon & Associates held 73 positions worth $263M, down 13% from $302M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Dillon & Associates's Q4 2018 filing shows 1 new, 23 increased, 30 reduced and 8 closed positions. Its largest new stake was Salesforce: 3,025 shares worth $414K. The largest sale was Celgene Corp, an estimated $607K.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Staples.
- Dillon & Associates's largest Q4 2018 buy was Salesforce: 3,025 shares worth $414K.
- Dillon & Associates added most to NVIDIA in Q4 2018, an estimated $954K increase.
- Dillon & Associates's biggest Q4 2018 reduction was Celgene Corp, cutting an estimated $607K.
- Dillon & Associates fully exited Core Laboratories in Q4 2018, selling an estimated $516K.
- Dillon & Associates's ten largest holdings make up 46% of its $263M portfolio in Q4 2018.
- Dillon & Associates opened 1 new position and closed 8 in Q4 2018.
- Dillon & Associates's portfolio value fell 13% quarter-over-quarter to $263M.
Based on Dillon & Associates's 13F filing for Q4 2018, filed 14 Feb 2019.